Penicillamine administration reverses the inhibitory effect of hyperhomocysteinaemia on endothelium-dependent relaxation in the corpus cavernosum in the rabbit

BJU International

Volumn 98, Issue 2, 2006, Pages 440-444

  Koupparis, Anthony J ^a   Jeremy, Jamie ^b   Angelini, Gianni ^a   Persad, Raj ^a   Shukla, Nilima ^b  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Copper; Erectile dysfunction; Homocysteine; Penicillamine; Rabbit

Indexed keywords

CHELATING AGENT; COPPER; HOMOCYSTEINE; HYDROGEN PEROXIDE; METHIONINE; NITRIC OXIDE; PENICILLAMINE; PEROXYNITRITE; PHENYLEPHRINE;

ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; COPPER BLOOD LEVEL; CORPUS CAVERNOSUM; ERECTILE DYSFUNCTION; HYPERHOMOCYSTEINEMIA; MALE; NONHUMAN; PENIS ERECTION; PRIORITY JOURNAL; RABBIT; RISK FACTOR; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM;

ANIMALS; CHELATING AGENTS; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; HYPERHOMOCYSTEINEMIA; MALE; METHIONINE; MUSCLE RELAXATION; PENICILLAMINE; PENIS; RABBITS;

EID: 33745684220     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.06212.x     Document Type: Article

References (38)

1. Cashen DE, MacIntyre DE, Martin WJ. Effects of sildenafil on erectile activity in mice lacking neuronal or endothelial nitric oxide synthase. Br J Pharmacol 2002; 136: 693-700
2. Gonzalez-Cadavid NF, Ignarro U, Rajfer J. Nitric oxide and the cyclic GMP system in the penis. Mol Urol 1999; 3: 51-9
3. Jeremy JY, Ballard S, Naylor A, Miller MAW, Angelini GD. Effects of sildenafil, a type-5 cGMP phosphodiesterase inhibitor, and papaverine on cyclic GMP and cyclic AMP levels in the rabbit corpus cavernosum in vitro. Br J Urol 1997; 79: 958-63
4. Sullivan ME, Thompson CS, Dashwood MR et al. Nitric oxide and penile erection: is erectile dysfunction another manifestation of vascular disease? Cardiovasc Res 1999; 43: 658-65
5. Jeremy JY, Angelini GD, Khan M et al. Platelets, oxidant stress and erectile dysfunction: an hypothesis. Cardiovasc Res 2000; 46: 50-4
6. Jones RW, Rees RW, Minhas S, Ralph D, Persad RA, Jeremy JY. Oxygen free radicals and the penis. Expert Opin Pharmacother 2002; 3: 889-97
7. Khan MA, Thompson CS, Jeremy JY, Mumtaz FH, Mikhailidis P, Morgan RJ. The effect of superoxide dismutase on nitric oxide-mediated and electrical field-stimulated diabetic rabbit cavernosal smooth muscle relaxation. BJU Int 2001; 87: 98-103
8. Thompson CS, Mumtaz FH, Khan MA et al. The effect of sildenafil on corpus cavernosal smooth muscle relaxation and cyclic GMP formation in the diabetic rabbit. Eur J Pharmacol 2001; 425: 57-64
9. Jeremy JY, Shukla N, Muzaffar S, Handley A, Angelini GD. Reactive oxygen species, vascular disease and cardiovascular surgery. Curr Vasc Pharmacol 2004; 2: 229-36
10. Loscalzo J. The oxidant stress of hyperhomocysteinaemia. J Clin Invest 1996; 98: 5-7
11. Jones RW, Jeremy JY, Koupparis A, Persad R, Shukla N. Cavernosal dysfunction in a rabbit model of hyperhomocysteinaemia. BJU Int 2005; 95: 125-30
12. Emsley AM, Jeremy JY, Gomes GN, Angelini GD, Plane F. Investigation of the inhibitory effects of homocysteine and copper on nitric oxide-mediated relaxation of rat isolated aorta. Br J Pharmacol 1999; 126: 1034-40
13. Khan MA, Thompson CS, Emsley AM et al. The interaction of homocysteine and copper markedly inhibits the relaxation of rabbit corpus cavernosum: new risk factors for angiopathic erectile dysfunction? BJU Int 1999; 84: 720-4
14. Clements PJ, Seibold JR, Furst DE et al. High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial: lessons learned. Semin Arthritis Rheum 2004; 33: 249-63
15. Ogihara H, Ogihara T, Miki M, Yasuda H, Mino M. Plasma copper and antioxidant status in Wilson's disease. Pediatr Res 1995; 37: 219-26
16. Martins da Costa C, Baldwin D, Portmann B, Lolin Y, Mowat AP, Mieli-Vergani G. Value of urinary copper excretion after penicillamine challenge in the diagnosis of Wilson's disease. Hepatology 1992; 15: 609-15
17. Ford ES. Serum copper concentration and coronary heart disease among US adults. Am J Epidemiol 2000; 151: 1182-8
18. Burkitt MJ. A critical overview of the chemistry of copper-dependent low density lipoprotein oxidation: roles of lipid hydroperoxides, alpha-tocopherol, thiols, and ceruloplasmin. Arch Biochem Biophys 2001; 394: 117-35
19. Koppenol WH. The Haber-Weiss cycle - 70 years on. Redox Rep 2001; 6: 229-34
20. Koppenol WH. The centennial of the Fenton reaction. Free Radic Biol Med 1993; 15: 645-51
21. Koupparis A, Jeremy JY, Persad R, Angelini GD, Shukla N. Smoking and erectile dysfunction: the role of NADPH oxidase. BJU Int 2004; 94: 257-8
22. Shukla N, Jones R, Persad R, Angelini GD, Jeremy JY. Hypercholesterolaemia and erectile dysfunction: role of superoxide generating enzymes and effect of a NO donating sildenafil derivative, NCX 911. Eur J Pharmacol 2005; in press
23. Kouparris A, Muzaffar S, Jeremy JY, Angelini GD, Shukla N. Sildenafil inhibits the formation of superoxide and the expression of gp47phox NADPH oxidase induced by the thromboxane A2 mimetic, U46619, in corpus cavernosal smooth muscle cells. BJU Int 2006; in press
24. Fox PL, Mazumder B, Ehrenwald E, Mukhopadhyay CK. Caeruloplasmin and cardiovascular disease. Free Radic Biol Med 2000; 28: 1735-44
25. Field LS, Luk E, Culotta VC. Copper chaperones: personal escorts for metal ions. J Bioenerg Biomembr 2002; 34: 373-9
26. Swain JA, Darley-Usmar V, Gutteridge JM. Peroxynitrite releases copper from caeruloplasmin: implications for atherosclerosis. FEBS Lett 1994; 342: 49-52
27. Kim RH, Park JE, Park JW. Ceruloplasmin enhances DNA damage induced by hydrogen peroxide in vitro. Free Radic Res 2000; 33: 81-9
28. Musci G, Fraterrigo TZ, Calabrese L, McMillin DR. On the lability and functional significance of the type I copper pool in ceruloplasmin. J Biol Inorg Chem 1999; 4: 441-6
29. Choi SY, Kwon HY, Kwon OB, Eum WS, Kang JH. Fragmentation of human ceruloplasmin induced by hydrogen peroxide. Biochimie 2000; 82: 175-80
30. Kang JH, Kim KS, Choi SY, Kwon HY, Won MH. Oxidative modification of human ceruloplasmin by peroxyl radicals. Biochim Biophys Acta 2001; 1568: 30-6
31. Held KD, Sylvester FC, Hopcia KL, Biaglow JE. Role of Fenton chemistry in thiol-induced toxicity and apoptosis. Radiat Res 1996; 145: 542-53
32. Kachur AV, Koch CJ, Biaglow JE. Mechanism of copper-catalyzed autoxidation of cysteine. Free Radic Res 1999; 31: 23-34
33. Kachur AV, Koch CJ, Biaglow JE. Mechanism of copper-catalyzed oxidation of glutathione. Free Radic Res 1998; 28: 259-69
34. Hultberg B, Andersson A, Isaksson A. The cell-damaging effects of low amounts of homocysteine and copper ions in human cell line cultures are caused by oxidative stress. Toxicology 1997; 123: 33-40
35. Fox PL, Mukhopadhyay C, Ehrenwald E. Structure, oxidant activity, and cardiovascular mechanisms of human caeruloplasmin. Life Sci 1995; 56: 1749-58
36. Shukla N, Thompson C, Angelini GD, Mikhailidis DP, Jeremy JY. Low micromolar concentrations of copper augment the impairment of endothelium-dependent relaxation of aortae from diabetic rabbits. Metabolism 2004; 53: 1315-21
37. Brewer GJ. Tetrathiomolybdate anticopper therapy for Wilson's disease inhibits angiogenesis, fibrosis and inflammation. J Cell Mol Med 2003; 7: 11-20
38. Stanger O, Semmelrock HJ, Wonisch W, Bos U, Pabst E, Wascher TC. Effects of folate treatment and homocysteine lowering on resistance vessel reactivity in atherosclerotic subjects. J Pharmacol Exp Ther 2002; 303: 158-62